Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1238837
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1238837
Real World Evidence Oncology Market with COVID-19 Impact Analysis, By Component, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 301 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Real World Evidence Oncology Market size was valued at USD 890.6 Million in 2022, expanding at a CAGR of 19.6% from 2023 to 2030.
Real-world evidence (RWE) is medical data acquired through RWD analysis on a medical product's use and prospective benefits or dangers. Many study designs or analyses, such as randomized trials, big simple trials, pragmatic trials, and observational studies, among others, might result in RWE.
Real World Evidence Oncology Market- Market Dynamics:
With the rise of precision medicine, oncologists are increasingly relying on genomic testing and other advanced diagnostic tools to tailor treatment plans to individual patients. RWE is essential in this process as it can help oncologists understand which treatments are most effective for specific patients based on their individual characteristics and medical history. These factors are expected to boost the growth of the real-world evidence oncology market. Further, the widespread adoption of EHRs has made it easier to collect and analyze RWE. This has allowed researchers and healthcare providers to access real-world data that can inform treatment decisions and drug development.
Furthermore, the growing importance patient reported outcome (PROs) is expected to fuel the market growth. Patients are increasingly taking an active role in their own care and are providing feedback on their treatment experience through PROs. RWE can help to capture and analyze this data, which can inform treatment decisions and improve patient outcomes. The oncology market has seen an explosion in new treatment options in recent years, including immunotherapies, targeted therapies, and combination therapies. RWE can help to inform the development and use of these treatments, as well as provide insights into their effectiveness and safety.
Real World Evidence Oncology Market- Segmentation Analysis:
The Global Real World Evidence Oncology Market is segmented on the basis of Component, Application, End User, and Region.
The market is divided into three categories based on Component: datasets, consulting & analytics, and services. The datasets segment dominates the market. The increasing need for medical data handling with real-time data which is mainly contributing to segment growth.
The market is divided into four categories based on Application: drug development, approval, market access, and post market surveillance. The drug development segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the demand drug development in cancer treatment.
The market is divided into three categories based on End User: pharmaceutical & biotech, healthcare payers and others. The pharmaceutical & biotech segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing demand for pharmaceutical & medical devices especially for drug development.
Real World Evidence Oncology Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
North America held the largest market share in 2021 and is projected to continue its dominance during the forecast period. The rising number for cancer cases and stiff regulations on drug approvals are contributing to market growth.
Real World Evidence Oncology Market- Competitive Landscape:
Due to the continued development in Real World Evidence Oncology technology in the coming years, the worldwide market for Real World Evidence Oncology is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including component costs, performance, products making, end user, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new Component launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in 2021, IQVIA holding Inc., has investment significant amount of money in drug development for cancer care through RWE analysis.
Key features of the study:
This proposed research study on Real World Evidence Oncology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Real World Evidence Oncology market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Real World Evidence Oncology market
Impact of COVID-19 on Real World Evidence Oncology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Real World Evidence Oncology market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Real World Evidence Oncology market, we have also included competitive landscape and key innovator analysis for the Real World Evidence Oncology market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Real World Evidence Oncology market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Real World Evidence Oncology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL REAL WORLD EVIDENCE ONCOLOGY MARKET KEY PLAYERS:
- IQVIA Holdings Inc
- ICON plc
- PPD, Inc.
- SYNEOS HEALTH, INC.
- CLARIVATE PLC
- Medpace Holdings Inc
- Symphony Innovation, LLC
- Clinigen Group plc
- Cognizant Technology Solutions Corporation
- Oracle Corporation
- PAREXEL International Corporation
- PerkinElmer, Inc.
- SAS Institute Inc.
- UnitedHealth Group Incorporated
- Flatiron Health
GLOBAL REAL WORLD EVIDENCE ONCOLOGY MARKET, BY COMPONENT:
- Datasets
- Consulting & analytics
- Services
GLOBAL REAL WORLD EVIDENCE ONCOLOGY MARKET, BY APPLICATION:
- Drug development
- Approval
- Market access
- Post market surveillance
GLOBAL REAL WORLD EVIDENCE ONCOLOGY MARKET, BY END USER:
- Pharmaceutical & biotech
- Healthcare payers
- Others
GLOBAL REAL WORLD EVIDENCE ONCOLOGY MARKET, BY REGION:
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1152
Table of Contents
1. Real World Evidence Oncology Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Real World Evidence Oncology Market Snippet by Component
- 2.1.2. Real World Evidence Oncology Market Snippet by Application
- 2.1.3. Real World Evidence Oncology Market Snippet by End User
- 2.1.4. Real World Evidence Oncology Market Snippet by Country
- 2.1.5. Real World Evidence Oncology Market Snippet by Region
- 2.2. Competitive Insights
3. Real World Evidence Oncology Key Market Trends
- 3.1. Real World Evidence Oncology Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Real World Evidence Oncology Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Real World Evidence Oncology Market Opportunities
- 3.4. Real World Evidence Oncology Market Future Trends
4. Real World Evidence Oncology Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Real World Evidence Oncology Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Real World Evidence Oncology Market Landscape
- 6.1. Real World Evidence Oncology Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Real World Evidence Oncology Market - By Component
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
- 7.1.2. Datasets
- 7.1.3. Consulting & analytics
- 7.1.4. Services
8. Real World Evidence Oncology Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Drug development
- 8.1.3. Approval
- 8.1.4. Market access
- 8.1.5. Post market surveillance
9. Real World Evidence Oncology Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 9.1.2. Pharmaceutical & biotech
- 9.1.3. Healthcare payers
- 9.1.4. Others
10. Real World Evidence Oncology Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Real World Evidence Oncology Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Real World Evidence Oncology Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Real World Evidence Oncology Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Real World Evidence Oncology Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Real World Evidence Oncology Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Real World Evidence Oncology Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. IQVIA Holdings Inc
- 11.2.2. ICON plc
- 11.2.3. PPD, Inc.
- 11.2.4. SYNEOS HEALTH, INC.
- 11.2.5. CLARIVATE PLC
- 11.2.6. Medpace Holdings Inc
- 11.2.7. Symphony Innovation, LLC
- 11.2.8. Clinigen Group plc
- 11.2.9. Cognizant Technology Solutions Corporation
- 11.2.10. Oracle Corporation
- 11.2.11. PAREXEL International Corporation
- 11.2.12. PerkinElmer, Inc.
- 11.2.13. SAS Institute Inc.
- 11.2.14. UnitedHealth Group Incorporated
- 11.2.15. Flatiron Health
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV1152
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Real World Evidence Oncology Market: Component Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Component
- TABLE Global Real World Evidence Oncology Market, by Component 2018-2030 (USD Million)
- TABLE Real World Evidence Oncology Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Real World Evidence Oncology Market, by Application 2018-2030 (USD Million)
- TABLE Real World Evidence Oncology Market: Regional snapshot (2022)
- TABLE Real World Evidence Oncology Market: End User Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Real World Evidence Oncology Market, by End User 2018-2030 (USD Million)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Real World Evidence Oncology Market, by Region 2018-2030 (USD Million)
- TABLE North America Real World Evidence Oncology Market, by Country, 2018-2030 (USD Million)
- TABLE North America Real World Evidence Oncology Market, by Component, 2018-2030 (USD Million)
- TABLE North America Real World Evidence Oncology Market, by Application, 2018-2030 (USD Million)
- TABLE North America Real World Evidence Oncology Market, by End User, 2018-2030 (USD Million)
- TABLE Europe Real World Evidence Oncology Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Real World Evidence Oncology Market, by Component, 2018-2030 (USD Million)
- TABLE Europe Real World Evidence Oncology Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Real World Evidence Oncology Market, by End User, 2018-2030 (USD Million)
- TABLE Asia Pacific Real World Evidence Oncology Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Real World Evidence Oncology Market, by Component, 2018-2030 (USD Million)
- TABLE Asia Pacific Real World Evidence Oncology Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Real World Evidence Oncology Market, by End User, 2018-2030 (USD Million)
- TABLE Latin America Real World Evidence Oncology Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Real World Evidence Oncology Market, by Component, 2018-2030 (USD Million)
- TABLE Latin America Real World Evidence Oncology Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Real World Evidence Oncology Market, by End User, 2018-2030 (USD Million)
- TABLE Middle East and Africa Real World Evidence Oncology Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Real World Evidence Oncology Market, by Component, 2018-2030 (USD Million)
- TABLE Middle East and Africa Real World Evidence Oncology Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Real World Evidence Oncology Market, by End User, 2018-2030 (USD Million)
List of Figures
- FIGURE Real World Evidence Oncology Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Component segment market share analysis, 2022 & 2030
- FIGURE Component segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Application segment market share analysis, 2022 & 2030
- FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE End User segment market share analysis, 2022 & 2030
- FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Real World Evidence Oncology Market share and leading players, 2022
- FIGURE Europe Real World Evidence Oncology Market share and leading players, 2022
- FIGURE Asia Pacific Real World Evidence Oncology Market share and leading players, 2022
- FIGURE Latin America Real World Evidence Oncology Market share and leading players, 2022
- FIGURE Middle East and Africa Real World Evidence Oncology Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Real World Evidence Oncology Market share analysis by country, 2022
- FIGURE Germany Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Real World Evidence Oncology Market share analysis by country, 2022
- FIGURE India Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Real World Evidence Oncology Market share analysis by country, 2022
- FIGURE Brazil Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Real World Evidence Oncology Market share analysis by country, 2022
- FIGURE Saudi Arabia Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Real World Evidence Oncology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.